Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs-Reference-Cited by-同舟云学术

Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs

Published:2024-01-30 Issue:3 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Su Xiaona¹,Zhou Ci²,Chen Shu¹,Ma Qiang³,Xiao He¹,Chen Qian¹,Zou Hua¹

Affiliation:

1. Department of Oncology, Daping Hospital, Army Medical Center of People's Liberation Army (Chongqing Daping Hospital), Chongqing 400042, P.R. China

2. Institute of Surgery Research, Daping Hospital, Army Medical Center of People's Liberation Army (Chongqing Daping Hospital), Chongqing 400042, P.R. China

3. Department of Pathology, Daping Hospital, Army Medical Center of People's Liberation Army (Chongqing Daping Hospital), Chongqing 400042, P.R. China

Publisher

Spandidos Publications

Reference40 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

3. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): A multicentre, open-label, phase 1/2 trial;Antonia;Lancet Oncol,2016

4. Therapy for Stage IV Non-Small-Cell lung cancer with driver alterations: ASCO living guideline;Singh;J Clin Oncol,2022

5. Recent advances in the management of lung cancer;Jones;Clin Med (Lond),2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens;Cellular Immunology;2024-05